Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) is technically challenging but increasingly performed in specialist centres. The aim of this study was to compare outcomes of exenteration over time. Methods This was a multicentre retrospective study of patients who underwent exenteration for LARC and LRRC between 2004 and 2015. Surgical outcomes, including rate of bone resection, flap reconstruction, margin status and transfusion rates, were examined. Outcomes between higher- and lower-volume centres were also evaluated. Results Some 2472 patients underwent pelvic exenteration for LARC and LRRC across 26 institutions. For LARC, rates of bone resection or flap reconstruction ...
Objective: To examine the changes in exenterative surgery over three decades analysing oncological o...
Objective: To assess the outcomes and patterns of treatment failure of patients who underwent pelvic...
Background: Despite multimodal therapy 5–15% of patients who undergo resection for advanced rectal...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
BackgroundPelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variable...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
Background Pelvic exenteration is the only radical treatment for locally advanced (ARC) or recurrent...
Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cance...
Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cance...
AIM To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced ...
Aim Pelvic exenteration surgery remains the only curative option for recurrent rectal cancer. Micros...
To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced prim...
SummaryBackgroundThe role of pelvic exenteration in locally advanced rectal cancer (LARC) has not be...
Objective: To examine the changes in exenterative surgery over three decades analysing oncological o...
Objective: To assess the outcomes and patterns of treatment failure of patients who underwent pelvic...
Background: Despite multimodal therapy 5–15% of patients who undergo resection for advanced rectal...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
BackgroundPelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variable...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
Background Pelvic exenteration is the only radical treatment for locally advanced (ARC) or recurrent...
Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cance...
Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cance...
AIM To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced ...
Aim Pelvic exenteration surgery remains the only curative option for recurrent rectal cancer. Micros...
To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced prim...
SummaryBackgroundThe role of pelvic exenteration in locally advanced rectal cancer (LARC) has not be...
Objective: To examine the changes in exenterative surgery over three decades analysing oncological o...
Objective: To assess the outcomes and patterns of treatment failure of patients who underwent pelvic...
Background: Despite multimodal therapy 5–15% of patients who undergo resection for advanced rectal...